Works by Sigvaldadottir, Ingibjorg

Results: 3
    1

    PTENP1-AS contributes to BRAF inhibitor resistance and is associated with adverse clinical outcome in stage III melanoma.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-89389-9
    By:
    • Vidarsdottir, Linda;
    • Azimi, Alireza;
    • Das, Ishani;
    • Sigvaldadottir, Ingibjorg;
    • Suryo Rahmanto, Aldwin;
    • Petri, Andreas;
    • Kauppinen, Sakari;
    • Ingvar, Christian;
    • Jönsson, Göran;
    • Olsson, Håkan;
    • Frostvik Stolt, Marianne;
    • Tuominen, Rainer;
    • Sangfelt, Olle;
    • Pokrovskaja Tamm, Katja;
    • Hansson, Johan;
    • Grandér, Dan;
    • Egyházi Brage, Suzanne;
    • Johnsson, Per
    Publication type:
    Article
    2
    3